SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi India MD outlines plans for rare disease, diabetes and haemophilia

Managing Director Deepak Arora said Sanofi India has growth plans in those segments and is not pursuing the GLP-1 category out of fear of missing out.

SANOFI

Related stories